Arkolith/Insider Trading/SYRS/Form 4

Roth David

Chief Medical OfficerSyros Pharmaceuticals, Inc. (SYRS) · full profile →Form 4 · filed Dec 8, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$25K
Net Open-Market Flow
-$25K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2023Sell(S)6K$3.95$25K6K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-069057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML